10-K annual report · filed Feb 12, 2026

Kimberly-Clark (KMB) FY2025 10-K Annual Report

Short answer

Kimberly-Clark (KMB) filed its fiscal 2025 10-K annual report with the SEC on Feb 12, 2026. It reported revenue of $16.4B (−18.0% year over year) and net income of $2.0B.

  • Top risk flagged: Regulatory risk from tightening data privacy and cybersecurity laws worldwide, increasing compliance costs and potential liabilities related to breaches of consumer data

FY2025 key financial metrics · XBRL

Revenue
$16.4B
−18.0% YoY
Net income
$2.0B
−20.6% YoY
Operating margin
14.3%
−1.7 pp YoY
Gross margin
36.0%
+0.2 pp YoY
EPS (diluted)
$6.07
−19.6% YoY
ROE
134.6%
−168.4 pp YoY
Operating cash flow
$2.8B
−14.1% YoY

Source: XBRL data from the Kimberly-Clark (KMB) FY2025 10-K on SEC EDGAR. USD.

Kimberly-Clark FY2025 10-K analysis

AI summary of each section, grounded in the filing text

Business Overview

  • Core business: global manufacturing and marketing of personal care, family care, and professional products with leading brands in 175+ countries
  • New strategic focus: 2024 Transformation Initiative emphasizing proprietary innovation, margin optimization, and organizational agility for growth
  • Major corporate transactions: agreement to acquire Kenvue, Inc. for $6.7 billion plus 280 million shares; formed joint venture divesting 51% of International Family Care and Professional segment for $1.7 billion
  • Employee base steady at ~36,000 with 35% in North America and half in manufacturing/distribution roles
  • Sustainability commitment: execution of climate goals approved by SBTi, targeting reduced fossil fuel plastics, forest fiber use, and greenhouse gas emissions with $150 million environmental compliance spend expected in 2026

Management Discussion & Analysis

  • Net sales $16.45B, down 2.1% YoY; organic sales up 1.7% driven by 2.5% volume growth, offset by divestitures and currency impacts
  • Gross margin 36.0% vs 37.4%, down 140 bps; operating profit $2.35B, down 12.9%; adjusted operating profit $2.73B, flat YoY
  • North America segment: sales $10.75B (-2.4%), operating profit $2.55B (+0.4%); International Personal Care sales $5.69B (-0.9%), operating profit $796M (-3.6%)
  • Operating cash flow $2.8B, down from $3.2B; ongoing capital allocation includes $1.7B expected from IFP joint venture sale, transformation initiative costs approx. $1.5B pre-tax
  • Management focused on 2024 Transformation Initiative to achieve $3B gross productivity savings by 2026; risks include birth rate declines, competitive pressures, input cost volatility, geopolitical uncertainties including Russia and Ukraine conflict impacts

Risk Factors

  • Regulatory risk from tightening data privacy and cybersecurity laws worldwide, increasing compliance costs and potential liabilities related to breaches of consumer data
  • Geopolitical exposure in Russia and surrounding region due to war in Ukraine, with operation curtailed and assets at risk of impairment
  • Supply chain vulnerability from sole-source commodity suppliers and third-party manufacturers, risking production delays and cost increases
  • Competitive pressure from private label manufacturers with lower production costs and e-commerce distribution intensifying market share threat
  • Financial risk of credit rating downgrade increasing borrowing costs and reducing access to commercial paper market for funding

Generated from the filing text; verify against the original. How to read a 10-K

Ask about this 10-K

Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.